POU-specrflc and POU-homeo domains of Oct3 were produced In Echerichia coll for characterization of DNA binding to the octamer sequence. POU domain protein Including A, B and H domains could bind to the octamer sequence efficiently and specifically, and DNase I footprint analysis gave an indistinguishable protection pattern between recombinant POU protein of Oct3 and native Oct3 from undlfferentlated P19 cells. Truncated mutants, which contained B-specific and H domains or the H domain only, showed no binding activity, indicating that both of POU-speciflc and POU-homeo domains are essential for binding activity to octamer sequence. Furthermore, a 6 amino acid deletion from the N-tenninal region of the A-specfflc domain is enough to destroy the binding activity. As for frans-activation, the N-termlnal region is essential and sufficient. Deletion of the N-termlnal proline-rich region rapidly eliminated trans-activating activity. These data strongly indicate the stringent Integrity requirements for both frans-activatlon and DNA-bindlng domains in Oct3.
INTRODUCTION
Many genes, which contribute to cell growth, differentiation and oncogenesis, are thought to be regulated at the transcriptional level (1, 2) . Recently, the genes of several fra/is-acting factors have been cloned (1) . These cDNAs have basically two domains; one is a DNA-binding domain and the other a rra/u-activating domain (1) . DNA-binding domains are classified into at least 4 groups having zinc-finger motif, helix-turn-helix motif, basic region/leucine zipper motif and a-helical structure, respectively (1) . Homeo boxes, having helix-turn-helix motifs, are found in many homeotic genes (3) . The POU families reported by Herr et al. (4) have POU-specific domains (A and B domains) in addtion to a POU-homeo domain. Three groups including ours have independently cloned an octamer binding factor, oct3, which is activated in undifferentiated embryonal carcinoma cells but is turned off upon differentiation (5, 6, 7 , Oct4 reported by Scholer et al. is same as Oct3 by two other groups). Rosner et al. show that Oct3 is a maternal factor required for the first mouse embryonic division (8) . The oct3 cDNA also has typical POUspecific and POU-homeo domains ( Fig. 1 ) like other POU family members, pit-1, octl, oct2, and unc-86 (4) . Oct3 protein has now been produced in Echerichia coli. We demonstrate here that both of POU-specific and POU-homeo domains are essential for full binding activity of Oct3.
Different types of fra/is-activating domains have been proposed (1) . These are acidic, glutamine-rich, serine/threonine-rich, proline-rich, and unclassified domains. One of them, the prolinerich (20-30%) domain has been found in CTF (9) , IRF-1 (10) and LAP/IL6-DBP (11, 12) . Oct3 also has two proline-rich regions in N-terminal and C-terminal regions (Fig. 1) . To characterize the fra/is-activation domain of Oct3, various mutants were constructed as a chimeric plasmid which carries c-Jun DNA binding domain. We also report here the mapping of Oct3 transactivating domain.
MATERIALS AND METHODS

Construction of plasmids
Expression plasmid pAR2113, which carries T7 promoter <£10, is a generous gift from Dr. F.W.Studier (13) . Truncated fragments of oct3 POU domain were synthesized by polymerase chain reaction (14). Primers for the N-terminal portion of the upper strand and the C-terminal portion of the lower strand contain a Ndel site, which includes the ATG start codon, and a BamHI site and complementary sequence of stop codon TAA, respectively. After gel purification and digestion with Ndel and BamHI, the fragment was cloned into the Ndel-BamHI site of pAR2113. The recombinant plasmid was transformed into Echerichia coli BL21(DE3) which carries T7 gene 1 under control of the lac UV5 promoter (13) . All sequences inserted were confirmed by the dideoxy method (15) .
Construction of p/3AOct3-Jun, which carries the N-terminal fra/w-activating domain of Oct3 and the DNA-binding domain of c-Jun, and p/3AAJun, which carries only the DNA-binding domain of c-Jun, have been described previously (5) . Other chimeric expression plasmids were constructed in a similar way. For p/3AJun-Oct3, which carries the DNA-binding domain of c-Jun followed by the C-terminal portion of Oct3, the Sal I-Hinc II fragment, containing the Jun binding domain from pjSAAJun, and the Hae II 0ocated at the nucleotide 870 of the Oct3 cDNA clone)-Bam HI fragment, containing the Oct3-coding region from amino acid residue 276 to the C-terminus, were ligated into Sal I-Bam HI site of pj3APr-l (16) . For p/3AOct3-Jun-Oct3, which carries the N-terminal /ra/w-activating domain of Oct3 in addition to the DNA-binding domain of c-Jun and the C-terminal portion of Oct3, the Pst I-Eco RI fragment containing DNA-binding domain of c-Jun linked to the C-terminal portion of Oct3 from p/3AJun-Oct3 and the Sal I-Pst I fragment containing the Nterminal mww-activating domain of Oct3 from the Oct3 cDNA, were ligated and subcloned at the Sal I-Eco RI site of Bluescript. The insert was excised as a Sal I-Bam HI fragment, and was subcloned at the corresponding sites of p/3APr-l.
For the AN series, various deletion fragments were obtained by polymerase chain reaction (14) as Nco I-Pst I fragments. These fragments were ligated to the Pst I-Bam HI c-Jun fragment and subcloned at the Nco I-Bam HI sites of p/3AOct3 (5) . Therefore, 5'-untranslated sequence and the intiation codon were provided from the Oct3 cDNA. For the AC series of deletion mutants, various Oct3 deletion fragments were synthesized by polymerase chain reaction and recovered as Sal I-Pst I fragments. These fragments were ligated into the Pst I-Bam HI c-Jun fragment and subcloned at the Sal I-Bam HI sites of p/?APr-l (16).
Production of protein in bacteria
For production of Oct3 protein in E. coli, overnight cultures were inoculated into 3ml of LB (Luria-Bertani) medium containing 100 /tg/ml of ampicillin, and incubated at 30°C to an optical density at 600nm of 0.4, then isopropyl thiogalactoside (IPTG) was added to a final concentration of lmM. Cells were harvested after a 2hr incubation, resuspended in 0.12M HM buffer (20 mM Hepes (pH 7.9), 1 mM MgCl 2 , 2 mM dithiothreitol, 17% glycerol and 0.12 M KC1), and disrupted by sonication. SDSpolyacrylamide gel electrophoresis (SDS-PAGE) was performed by using Phast System (Pharmacia). The amounts of POU proteins produced in bacteria were estimated by the staining with silver or coomasie brilliant blue. In some cases, POU protein was partially purified by heparin-agarose column chromatography (17) , and amount of protein determined by silver staining.
DNA-binding analyses
Two complementary 26bp oligonucleotides (OCTA26) were synthesized (5) as a probe for gel shift assay as follows.
5'GATCAGTACTAATTAGCATTATAAAG3'
3 'TC ATGATTAATCGTAATATTTCCTAG5' 5'-Overhangs were filled in by using Klenow fragment. Crude cytosolic fractions were used for all gel shift assays. For DNase I footprint analysis, the cytosolic fraction was loaded to a heparinagarose column and eluted with HM buffer containing 0.6M or 1M KC1. Protein fraction (6.25^1) was mixed with 6.25 /tl of 20 mM Tris (pH7.5), 10% glycerol, 2 mM dithiothreitol, 20 mM EDTA, 0.32 mg/ml poly (dl-dC) and radio-labeled probe (10,000 cpm/10 fmol). Binding reaction was performed at room temperature for 30 min. Each reaction was loaded on a 4% nondenaturing polyacrylamide gel, electrophoresed at 150 V for 1 hr, fixed with 10% methanol and 10% acetic acid, and autoradiographed overnight at -80°C. Footprint analysis was performed as described (17, 18) .
Transfection experiment
Transfection and CAT (chroramphenicol acetyltransferase) assay were performed as described previously (5) . For each assay, 10 fig of the reporter plasmid (pIFNcat-3TRE) (5), 5 /tg of effector plasmid and 10 /xg of carrier plasmid (Bluescript) were transfected into P19 cells. All the transfection experiments were performed at least twice, and a representative experiment is shown. In some experiments, the transfection efficiency was checked by the transfection with pRSVGAL, an eukaryotic expression vector which contained the Escherichia coli-figalactosidade (lacZ) structural gene controlled by Rous sarcoma virus LTR (19) . It was comfirmed that the variation of transfection efficiency was less than 20%.
RESULTS
Production of recombinant POU protein of OCT3 in E.coli
The binding domain of Oct families consists of POU-specific and POU-homeo domains (4). For characterization of the binding ability of POU protein to the octamer sequence, various mutants were constructed. The fragment was obtained by polymerase chain reaction and cloned into a pAR2113 expression vector, which carries T7 promoter ( 
Binding of POU(ABH) protein to the octamer sequence
The ability of recombinant POU(ABH), which included the whole portion of POU-specific and POU-homeo domains, to bind the octamer sequence was investigated. By using OCTA26 corresponding to 26mer oligonucleotides, gel shift assay was performed (Fig.4-A) . In the case of POU(ABH), most of the protein was found in the precipitate fraction. However, its cytosol fraction turned out to have sufficient POU(ABH) protein for the 2*2 297 352 COOH Pro-rich POU-ip*clflc POUPro-rich homto Figure 1 . Schematic structure of Oct3. Oct3 protein consists of 352 amino acids as described by Rosner et al., (7) . DNA-binding domain (POU-specific domains A and B, and POU-homeo domain) and the two proline-rich regions are shown. Numbers indicate those of amino acid residues from N-terminal portion according to the sequence reported by Rosner et al., (7) . POU domain starts at 127 (7) and POU-specific domain A starts at 135 (5).
binding assay. Shifted band were observed with the increasing amount of the cytosol fraction containing POU(ABH) protein.
The addition of non-labelled oligonucleotide abolished the shifted band, indicating that this band was due to specific binding. We further characterized the binding of POU(ABH) by DNase I footprint analysis. The nuclear extract of undifferentiated PI9 cells gave a clear protection on the region of octamer sequence in mouse embryonic stem cell-specific enhancer El (Fig. 4-B , see also ref.5). POU(ABH) protein, partially purified by heparinagarose chromatography, revealed an almost identical protection pattern by footprint analysis. This strongly suggests that POU(ABH) domain is enough for binding of Oct3 to octamer sequence. These data also indicate that almost all POU(ABH) proteins in cytosolic fraction are active, since 5-10 ng of POU(ABH) of the 0.6M heparin-agarose eluted fraction gave a complete protection pattern in DNase I footprint analysis using 10 fmol probe (Fig. 4-B) , and as little as 1 ng of POU(ABH) in 0.6M fraction could also give a measurable protection pattern (data not shown).
Loss of binding ability of further truncated mutants
We next used the further truncated mutants for the gel shift assay. When we used the same molar amounts (5-7 ng protein estimated by silver staining) of POU(BH) and POU(H) proteins as POU(ABH) protein, POU(BH) and POU(H) did not bind to OCTA26 (data not shown). Even using a maximum volume (6.25 ^1) of undiluted cytosol fraction of POU(BH) (100 ng) and POU(H) (200 ng), no binding was observed (Fig. 5, Lane 7,8) . Furthermore, a ten fold higher concentration of the probes still revealed no significant binding (data not shown). This indicates that the binding affinities of POU(BH) and POU(H) are negligible compared with that of POU(ABH). A N-terminal deletion of POU A domain also showed the loss of binding ability (Fig. 5, Lane  3 -6) . Indeed, as little as a 6 amino acid deletion of the N-terminal portion of the POU A domain (POU(A7ABH)) was sufficient for the loss of binding activity (Fig. 5, Lane 3) . 
7ra/u>-activating domain of Oct3 is contained in the aminoterminal region
The amino-terminal region of Oct3 is rich in proline. In fact, between residues 13 to 60, 23% are proline (Fig. 1) . We have previously shown that the arnino-terrninal region (residues 1 to 134) functions as a rra/u-activating domain when fused to the DNA-binding domain of c-Jun. The C-terminal region of Oct3 is also proline-rich (Fig.l) ; of residues 297 to 348, 25% are proline [There was a sequence error in our previous paper (5) . GG at nucleotide 932 -933 in that paper should have been GGG. We have confirmed the sequence with our cDNA clones, and it is identical to the one reported by Scholer et al. (6) and Rosner et al. (7)]. We therefore examined whether the C-terminal region also participates in rra/is-activation. Various OcG/c-Jun chimeric expression vectors were constructed (Fig.6 ). p|3AOct3-Jun contains the N-terminal region of Oct3 linked to the c-Jun DNA binding domain, whereas p/3AJun-Oct3 has the C-terminal region of Oct3 in addition to c-Jun DNA binding domain. p/3AOct3-JunOct3 posseses both the N-terminal and C-terminal regions of Oct3 in addtion to c-Jun DNA binding domain. 7ra/w-activation by each construct was examined in PI9 EC cells, which are known to have very low levels of endogeneous c-Jun. While pj3AOct3-Jun showed a strong fra/w-activation, as we reported previously (5), p/3AJun-Oct3 failed to activate the reporter gene. Moreover, the level of tavw-activation by p(3AOct3-Jun-Oct3 was indistinguishable from that of p/SAOct3-Jun. These results establish that the dominant transactivating domain of Oct3 protein is located in the N-terminal region, although the possibility that C-terminus proline rich region plays a small role in fra/w-activation can not be completely excluded.
Deletion mapping of the Oct3 /rans-activating domain
The N-terminal rra/w-activating domain of Oct3 was further defined by deletion mutagenesis. Starting with p/3AOct3-Jun as a wild-type, various deletion mutants were constructed. In one series of mutants (AN), the deletion starts at residue 2 and proceeds toward the C-terminus. In another series of mutants (AC), the deletion starts at residue 134 and proceeds toward the N-terminus. Each deletion mutant was examined for its ability to stimulate the transcription of the reporter gene (Fig.7) . AN2/36, the deletion mutant, lacking residues 2 to 36 showed a significant reduction of activation. Further deletions toward the C-terminus eliminated the activity. For deletion mutants from C-terminus, deletion of residues 121 to 134 did not affect the activity, but further deletions toward the N-terminus resulted in the complete loss of the activity. From these results, the minimal region required for the full level fra/iy-activation was localized between residue 1 to 120. Thus essentially the whole N-terminal portion of Oct3 is necessary for rra/u-activation.
DISCUSSION
Recently, a specific structural motif designated as the POU domain has been proposed for a large family of rra/u-acting factors (4). This consists of two domains, POU-specific (A and B) and POU-homeo domains. The homeo domains in homeotic genes have enough DNA binding capacity to their target sequences (3). However, it seems that although the POU-homeo domain in POU family genes is essential for DNA binding (21), it is not sufficient for efficient binding to the cognate sequence. Indeed, the POU-homeo domain proteins of Octl and Pit-1 bind 100-600 fold less efficiently to their respective elements than the proteins consisting of both POU-specific and POU-homeo domains (22, 23) . Mutations in POU-specific A domain and B domain also abolished the detectable binding of Octl (24) . In the reports described above, however, additional amino acids were attached to the N-terminal portion for making a fusion protein. In contrast, proteolytic clipping assay of Oct4 (the same protein as our Oct3 in this paper) revealed that Mr of the minimum DNA binding domain was -11,000, corresponding to 100 amino acids. The N-terminal border of Oct4 would coincide with the borders between subdomain A and B of POUspecific domain (6) , although the exact N-terminal and C-terminal borders of the protein were not shown. To avoid the contribution of unrelated amino acid sequences and to determine the exact N-terminal boundary, we used a PCR protocol and introduced a methionine ATG codon just upstream of the N-terminal border and a stop codon just downstream of the C-terminal border. Using these truncated and simplified proteins, we characterized the contribution of POU-specific domain of Oct3 to the binding. Neither POU(BH) nor POU(H) showed any binding activity. Moreover, it is of quite interest that only a 6 amino deletion from the N-terminal portion of POU-specific domain completely eliminated binding activity. Several boxes in POU-specific A domain are conserved among Oct families (Fig. 2-B) . Deletion of half of the first conserved box is enough for destroying binding activity, strongly suggesting that the whole region of POUspecific domain is essential for the high affinity binding of Oct3. Verrijzer et al. concludes that octamer can activate as a bipartite recognition sequence for Octl and that POU-specific domain contributes to binding affinity, as well as to the specificity, by providing additional contacts, although POU-specific domain itself has no binding activity (22) . We consider Verrijzer's conclusion is very likely, and one may expect the intra-molecular cooperative binding of POU-specific and POU-homeo domains to the octamer sequence just as the inter-molecular cooperative binding of Jun-Fos complex to API site (25) . Indeed, neither POU-specific domain nor Fos itself can bind to the DNA directly. Three-dimentional analysis of POU-specific and POU-homeo domains should clarify the molecular mechanisms of their cooperative binding to DNA. Protein-protein interactions as reported by Ingraham on Pit-1 (23) also remain to be investigated.
The DNA binding domain of Oct3 has been roughly delineated by Scholer et al., (6, referred by them as Oct4). It is demonstrated that a POU domain lacking part of the POU-specific domain can still bind to octamer sequence if the C-terminal region is present. In the cases of Octl and Oct2A, the deletion of the N-terminus of POU-specific domain caused to decrease the binding affinity even still having C-terminal portion of the genes (24, 26) . Therefore, unlike Octl and Oct2A, the C-terminal region of Oct3 must also contribute to DNA-binding (6) . It is not likely that there is some discrepancy between this results and ours. Rather, not only the POU-specific domain but also the C-terminus of the gene are essential for full DNA-binding, and both regions make a more stable DNA-protein complex in vivo.
We also characterized the mwty-activarion domain of Oct3. Rosner et al., (7) and Scholer et al., (27) have already demonstrated that Oct3 acts as a /ra/w-activator in HeLa cells using reporter plasmid which contains the octamer sequence located near the TATA box of rabbit /3-globin, and carries a SV40 enhancer downstream of the /3-globin gene (26, 28) . This reporter plasmid was also used for the demonstration of fra/is-activation by Oct6 in HeLa cells (29) , though there is some distance effect between the octamer and TATA box (27, 29) , and the possibility of either an inhibtory factor present in HeLa cells or a stimulatory factor present in the ES and EC cells would be elucidated (27, 29) . We utilized a chimeric construct as a effector plasmid; hybrid of fram-activating region of Oct3 and DNA-binding region of c-Jun. Our results indicate the the N-terminal region (residue 1 to 120) is necessary and sufficient for rra/is-activating function of Oct3. Scholer et. al (6) have reported that two types of Oct3 proteins with different molecular sizes are synthesized in F9 cells from Oct3 gene. The larger one (referred as Oct4 by Scholer et. al) would correspond to the polypeptide from residue 1 to 352. The smaller one (referred as Oct5 by them), presumably generated by different usage of initiation codon, would contain residues 68 to 352. Based on our deletion mapping of the transactivation domain, the smaller Oct3 protein should lack the transactivating function. It is therefore tempting to speculate that the smaller Oct3 (or Oct5) counteracts the larger Oct3 by competitive binding to octamer sequences. It may be that /ram-activating function of Oct3 is regulated by the balance of two proteins. 7ra/w-activation domains of several transcription factors are known to be rich in proline [CTF (9) , IRF (10), and LAP/IL6DBP (11, 12) ]. The Oct3 fra/u-activating domain (residue 1 to 121) is also rich in proline; of residues 13 to 60, 23% are proline. In amino acid sequence homology search, Oct3 fra/w-activating domain shows a homology to other proline-rich sequences: if included equivalent amino acids, CTF; 38% homology in 61 amino acid residues from N-terminal portion of Oct3, LAP/IL6-DBP; 27% homology and IRF-1; 22% homology in 134 amino acid residues of N-terminal Oct3 fra/w-activating domain. However, the C-terminal region of Oct3 protein which is very rich in proline as well, is not involved in mom-activation, although it shows a 15% homology to the N-terminal prolinerich region. Apparently, it is not proline-richness per se that confers the /ra/ts-activating function and it remains to be determined what structural feature is critical to the Oct3 transactivating domain.
